New York State Common Retirement Fund’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
27,849
+6,836
| +33% | +$365K | ﹤0.01% | 1514 |
|
|
2025
Q1 | $851K | Hold |
21,013
| – | – | ﹤0.01% | 1699 |
|
|
2024
Q4 | $585K | Hold |
21,013
| – | – | ﹤0.01% | 1886 |
|
|
2024
Q3 | $603K | Sell |
21,013
-9,065
| -30% | -$260K | ﹤0.01% | 1869 |
|
|
2024
Q2 | $706K | Sell |
30,078
-4,660
| -13% | -$109K | ﹤0.01% | 1909 |
|
|
2024
Q1 | $877K | Buy |
34,738
+193
| +0.6% | +$4.87K | ﹤0.01% | 1835 |
|
|
2023
Q4 | $807K | Buy |
34,545
+1,214
| +4% | +$28.4K | ﹤0.01% | 1887 |
|
|
2023
Q3 | $1.69M | Buy |
33,331
+6,159
| +23% | +$312K | ﹤0.01% | 1512 |
|
|
2023
Q2 | $1.27M | Sell |
27,172
-510
| -2% | -$23.8K | ﹤0.01% | 1672 |
|
|
2023
Q1 | $1.06M | Sell |
27,682
-4,947
| -15% | -$189K | ﹤0.01% | 1849 |
|
|
2022
Q4 | $1.79M | Buy |
32,629
+12,392
| +61% | +$679K | ﹤0.01% | 1699 |
|
|
2022
Q3 | $689K | Buy |
20,237
+2,055
| +11% | +$70K | ﹤0.01% | 2172 |
|
|
2022
Q2 | $172K | Sell |
18,182
-40
| -0.2% | -$378 | ﹤0.01% | 2861 |
|
|
2022
Q1 | $259K | Buy |
18,222
+25
| +0.1% | +$355 | ﹤0.01% | 2713 |
|
|
2021
Q4 | $385K | Sell |
18,197
-69
| -0.4% | -$1.46K | ﹤0.01% | 2579 |
|
|
2021
Q3 | $408K | Sell |
18,266
-3,838
| -17% | -$85.7K | ﹤0.01% | 2576 |
|
|
2021
Q2 | $548K | Buy |
22,104
+8,704
| +65% | +$216K | ﹤0.01% | 2550 |
|
|
2021
Q1 | $389K | Hold |
13,400
| – | – | ﹤0.01% | 2556 |
|
|
2020
Q4 | $346K | Buy |
13,400
+3,300
| +33% | +$85.2K | ﹤0.01% | 2523 |
|
|
2020
Q3 | $311K | Hold |
10,100
| – | – | ﹤0.01% | 2451 |
|
|
2020
Q2 | $252K | Buy |
10,100
+4,800
| +91% | +$120K | ﹤0.01% | 2543 |
|
|
2020
Q1 | $112K | Hold |
5,300
| – | – | ﹤0.01% | 2713 |
|
|
2019
Q4 | $118K | Hold |
5,300
| – | – | ﹤0.01% | 2957 |
|
|
2019
Q3 | $121K | Buy |
+5,300
| New | +$121K | ﹤0.01% | 2978 |
|